Global Pricing Innovations and Partners4Access announce a Strategic Partnership to deliver integrated price and access solutions for pharmaceutical launch success

Strategic partnership formed to support collaboration and innovation. The Core focus is 'Orphan Drug Solutions' & Price and Access through data analytics and modelling. End Quote

(1888PressRelease) September 07, 2016 - LONDON - Global Pricing Innovations, the pricing experts, has formally partnered with Partners4Access, the global access experts for orphan drugs; this new synergy will ensure unmatched service within the pharma pricing industry. The Global Headquarters for both companies will be in a newly refurbished, larger and easily accessible office in Euston, London

Patel "When two companies share similar values, it is a great foundation for a strategic partnership. The common vision we share in creating innovative price and access solutions for our clients, makes the partnership an obvious choice. Our combined knowledge and strengths will promote synergy and ensure high quality service to all our clients." Schmitz added "The choice of London as an HQ is important for us to be close to our European and US clients. London has long been a hub of innovation for the pharmaceutical industry."

GPI and P4A are growing rapidly thanks to its top managers who have extensive experience within the life science industry. Schmitz and Patel have an impeccable eye for talent and have managed to pool together the best minds from all across the globe including Germany, France, Spain, Italy, the UK and the US. The team is supported by an offshore presence in Asia. Schmitz "Our talent management strategy has a bias towards diversity; as a result, the heterogeneity within our teams helps us to provide innovative approaches for our clients and constantly push boundaries. We have no intentions of staying still!"

Patel adds, "We are excited about the future. This rapid growth and client satisfaction is proof that we have the ship going in the right direction."

ABOUT GPI
Global Pricing Innovations (GPI), the pricing experts, have an ambitious goal: to drive pricing excellence across the life sciences industry. GPI has become known by some clients as the "decision enabler" through the combination of their robust data-driven-insights and bespoke analytical solutions. The team uses a combination of transparent modelling and enriched data to give pharmaceutical companies the all critical competitive advantage when making pricing decisions.

For more information visit us at: www.globalpricing.com
Or call us on: +44 20 3874 3050

ABOUT P4A
Partners4Access is a global consultancy specialised in access for orphan drugs. The company support the biotechnology industry along their launch journey from as early as phase II clinical trial design, to help secure successful price and access for orphan drugs. Partnership is a fundamental part of the approach with clients; as such the P4A team has partnered with many US and EU based biotechs to help them successfully launch their first orphan drug globally. The company work with pharmaceutical clients across a 5 stage journey which they use to help evaluate, shape and deliver orphan drug value.

For more information contact Partners4Access at www.partners4access.com
Or call us on: +44 20 3874 3050

###

space

Other Related Press Releases